ADVERTISEMENT
Mary Jeanne Kreek, heroin, addiction, methadone, drug addiction, The Rockefeller University,
Mary Jeanne Kreek, Methadone Developer, Dies at 84
A physician and neurobiologist at the Rockefeller University who specialized in addiction research, Kreek was best known for her work on developing the treatment for heroin addiction.
Mary Jeanne Kreek, Methadone Developer, Dies at 84
Mary Jeanne Kreek, Methadone Developer, Dies at 84

A physician and neurobiologist at the Rockefeller University who specialized in addiction research, Kreek was best known for her work on developing the treatment for heroin addiction.

A physician and neurobiologist at the Rockefeller University who specialized in addiction research, Kreek was best known for her work on developing the treatment for heroin addiction.

translational science

Timothy Lu: Niche Perfect
Kerry Grens | May 1, 2016 | 2 min read
Associate Professor, Departments of Electrical Engineering & Computer Science and Biological Engineering, MIT. Age: 35
Lu on Syn Bio
The Scientist Staff | Apr 30, 2016 | 1 min read
MIT researcher and Scientist to Watch Timothy Lu talks about the value of cross-disciplinary approaches in bringing synthetic biology into the clinic.
Making Scientific Strides in the Produce Aisle
Science Philosophy in a Flash - Making Scientific Strides in the Produce Aisle
Iris Kulbatski, PhD | 1 min read
Andrew Pelling shares how pursuing knowledge for its own sake breaks down interdisciplinary barriers and lays the foundation for ground-breaking research.
Pet Scans
Amy K. LeBlanc, Timothy M. Fan, and Nicola Mason | Apr 1, 2016 | 4 min read
Studying tumor development and treatment in dogs and cats, in parallel with research on rodents and humans, could improve the successful translation of new cancer drugs.
Opinion: Translation Nation
Kathleen Marsman and Lisa McKerracher | Nov 18, 2015 | 3 min read
What’s in store for commercialization grants at the Canadian Institutes of Health Research?
New Scripps Research Institute Leadership
Jef Akst | Sep 20, 2015 | 2 min read
The nonprofit institution names a new CEO and president.
Opinion: Star Trek Medicine
Dean Tantin | Nov 6, 2014 | 3 min read
An apology for basic research
Opinion: Overcoming Cancer’s Complexities
Daniel S. Kapp, David Rubenson, and Beverly Mitchell | Apr 11, 2014 | 4 min read
Considering “targeted therapeutics” in the face of intra-patient heterogeneity. 
Next Generation: Cancer Cell Protein Profiling
Abby Olena, PhD | Jan 15, 2014 | 4 min read
Antibody barcoding allows scientists and clinicians to analyze protein expression in small amounts of cancer tissue.
Week in Review: January 6–10
Tracy Vence | Jan 10, 2014 | 3 min read
Bacterial genes aid tubeworm settling; pigmentation of ancient reptiles; nascent neurons and vertebrate development; exploring simple synapses; slug-inspired surgical glue
Report Card: Sharing Animal Research
Tracy Vence | Jan 8, 2014 | 1 min read
New analysis finds that funding agencies, scientists, and journals are not including sufficient information when reporting on in vivo experiments.
Building Support for Basic Research
Tracy Vence | Dec 16, 2013 | 2 min read
The push toward translational research was a much-discussed topic at the annual American Society for Cell Biology meeting.
Opinion: Predicting Perfect Storms
Magali Haas | Oct 30, 2013 | 3 min read
On embracing technology and collaboration to tackle brain disorders like multiple sclerosis
Week in Review: September 23–27
Tracy Vence | Sep 27, 2013 | 4 min read
Antibiotic cycling makes a comeback in the lab; how life scientists can learn from astronauts; napping to conquer fears; deconstructing the cancer R&D crisis
Opinion: Reasons for the R&D Crisis
Jan Brábek and Michael Fernandes | Sep 23, 2013 | 3 min read
Response to an opinion in The Scientist charting current pitfalls in translational research
Week in Review: September 9–13
Tracy Vence | Sep 13, 2013 | 3 min read
A new type of stem cell; a parasitic ant species protects its hosts; reasons for biodiversity among tropical amphibians; transforming translational research
Opinion: Translational Research in Crisis
Masoud H. Manjili | Sep 10, 2013 | 4 min read
Turning discoveries made in academic labs into innovative therapies requires a radically new approach.
Lost in Translation
Ruth Williams | Jul 16, 2013 | 3 min read
Failure to translate preclinical research to humans may be due in part to biased reporting.
Worried Sick
Megan Scudellari | Jul 1, 2013 | 10+ min read
Expectations can make you ill. Fear can make you fragile. Understanding the nocebo effect may help prevent this painful phenomenon.
ADVERTISEMENT